title: Phase II trials of trimetrexate in advanced adult soft tissue sarcoma. Studies of the Canadian Sarcoma Group and the National Cancer Institute of Canada Clinical Trials Group.
authors.affiliation: National Cancer Institute of Canada Clinical Trials Group, Queen's University, Kingston, Ontario.
authors.forename: E A
authors.initials: EA
authors.lastname: Eisenhauer
authors.forename: R
authors.initials: R
authors.lastname: Wierzbicki
authors.forename: M
authors.initials: M
authors.lastname: Knowling
authors.forename: V H
authors.initials: VH
authors.lastname: Bramwell
authors.forename: I C
authors.initials: IC
authors.lastname: Quirt
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002170:Canada; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D005260:Female; D006077:Government Agencies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D012509:Sarcoma / Q000188:drug therapy*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy*; D016597:Trimetrexate / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D016597:Trimetrexate